e-learning
resources
Glasgow 2004
Monday 06.09.2004
A translational approach to mechanisms of lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Growth factors in chronic obstructive pulmonary disease
J. Sauleda, A. Noguera, D. Blanquer, A. Fuster, A. R. Pons, J. Pons, A. Agusti (Palma Mallorca, Spain)
Source:
Annual Congress 2004 - A translational approach to mechanisms of lung disease
Session:
A translational approach to mechanisms of lung disease
Session type:
Thematic Poster Session
Number:
2040
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Sauleda, A. Noguera, D. Blanquer, A. Fuster, A. R. Pons, J. Pons, A. Agusti (Palma Mallorca, Spain). Growth factors in chronic obstructive pulmonary disease. Eur Respir J 2004; 24: Suppl. 48, 2040
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Rhinovirus-infection in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002
Periodontitis and chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006
Risk factors for chronic obstructive pulmonary disease in women
Source: Eur Respir J 2002; 20: Suppl. 38, 326s
Year: 2002
Comorbidities in the course of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
Chronic obstructive pulmonary disease
Source: Eur Respir Mon; 2009: 45: 25–31
Year: 2009
Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2014; 65: 1-17
Year: 2014
Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2015; 70: 80-98
Year: 2015
Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2013; 62: 1-18
Year: 2013
Inflammation and depression in chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 718s
Year: 2007
Anemia in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012
Genetic risks in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 454s
Year: 2003
Angiogenic status in patients with chronic obstructive pulmonary disease.
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Cardiovascular risk factors in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006
Erythropoietin dysregulation in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008
Determinants of depression at exacerbation in chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007
Pulmonary hypertension associated with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 656s
Year: 2006
Systemic effects of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 347-360
Year: 2003
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012
Comorbidities in chronic obstructive pulmonary disease: Prognostic factors?
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept